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ABSTRACT 
Regarding the inadequate healing capability of cartilage tissue, cell-based therapy is making the future of cartilage 
repair and regeneration. Mesenchymal stem cells (MSC) have shown great promise in cartilage regeneration. How-
ever, a yet-unresolved issue is the emergence of hypertrophic and pathologic markers during in vitro MSC chon-
drogenesis. Articular chondrocytes (AC) can suppress the undesired hypertrophy when co-cultured with MSC. On 
the other hand, platelet rich plasma (PRP), is considered potentially effective for cartilage repair and in-vitro chon-
drogenesis. We thus aimed to harness chondro-promotive effects of PRP and hypertrophic-suppressive effects of 
AC:MSC co-culture to achieve a more functional cartilage neo-tissue. We used PRP or conventional-differentia-
tion chondrogenic media (ConvDiff) in MSC mono-cultures and AC:MSC co-cultures. We assessed gene expres-
sion of chondrogenic and hypertrophic markers using real-time RT-PCR and immunostaining. Alkaline-phospha-
tase activity (ALP) and calcium content of the pellets were quantified. We also measured VEGF and TNF-α se-
cretion via ELISA. We showed PRP had higher chondrogenic potential (in mRNA and protein level) and hyper-
trophic-suppressive effects than Conv-Diff (mRNA level). Co-culturing reduced ALP while PRP increased cal-
cium deposition. In all four groups, TNF-α was down-regulated compared to MSC controls, with co-cultures re-
ceiving ConvDiff media secreting the least. Meanwhile, the only group with increased VEGF secretion was PRP-
mono-cultures. We observed synergistic effects for PRP and AC:MSC co-culture in enhancing chondrogenesis. 
Inclusion of AC reduced hypertrophic markers and angiogenic potential in PRP groups. We thus propose that 
combination of PRP and co-culture would favor chondrogenesis while alleviate but not totally eradicate undesired 
hypertrophic and pathologic responses. 
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INTRODUCTION 
Articular cartilage tissue creates a smooth 
surface which facilitates joint movement 
(Becher et al., 2010). Once injured, this tissue 
has limited ability to repair itself which in turn 
can lead to lesion progression and finally os-
teoarthritis (Ahern et al., 2009; Bedi et al., 
2010). The lack of efficient pharmacologic 
treatments along with inherent inefficiency of 
the healing process has extended the cell-
based methodologies for cartilage repair ei-
ther by replacement or reparative procedures. 
Autologous chondrocytes (AC) have been 
successfully used for in vivo grafting into 
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chondral lesions (Acharya et al., 2012). They 
are able to produce stable and non-mineral-
ized cartilage tissue. However, it is difficult to 
obtain enough of chondrocytes which is due 
to the small biopsied sample, the resultant do-
nor tissue morbidity and limited chondrocyte 
proliferation potential. Chondrocyte dediffer-
entiation after extensive in vitro propagation 
is another drawback (Cooke et al., 2011). On 
the other hand, mesenchymal stem cells 
(MSC), as an alternative autologous source, 
have excellent potential for chondrogenesis. 
These cells could be easily obtained from dif-
ferent sources with bone marrow and adipose 
tissue being the most studied, available and 
promising sources (Shafiee et al., 2016). 
MSC’s self-renewal potential is superior to 
chondrocytes in terms of speed, passage num-
ber and maintenance of immuno/phenotypic 
characteristics during in vitro propagation 
(Farrell et al., 2011; Marquass et al., 2011; 
O'Sullivan et al., 2011; Acharya et al., 2012). 
Moreover, MSCs secrete several cytokines 
and growth factors with immuno-modulatory 
effects, which enable them with a unique ther-
apeutic role in osteoarthritis or rheumatoid ar-
thritis diseases (Mamidi et al., 2016). How-
ever, regarding the complex molecular mech-
anism of chondrogenesis, strong inductive 
and directive signals are required to differen-
tiate MSCs into chondrocytes (Bian et al., 
2011). Yet unresolved drawbacks with MSC, 
including unwanted hypertrophy reminiscent 
of endochondral ossification and emergence 
of some cartilage pathologic markers such as 
angiogenic features, can restrain their robust-
ness (Dickhut et al., 2009). This implies that 
more research is needed in order to prevent or 
minimize such impediments via developing 
new protocols that induce maximal chondro-
genesis with minimal hypertrophy, as is desir-
able for cartilage repair interventions. 
Autologous platelet rich plasma (PRP) as 
a blood supply with high concentration of the 
platelets (Smyth et al., 2012) is considered a 
valuable source for healing process enhance-
ment in various cases, being clinically in use 
for tissue repair purposes (Boswell et al., 
2012; Lee et al., 2012). Upon activation, al-
pha granules as a rich source of numerous 
growth factors such as transforming growth 
factor beta (TGF-β), vascular endothelial 
growth factor (VEGF), platelet derived 
growth factor (PDGF), insulin-like growth 
factor (IGF) and basic fibroblast growth fac-
tor (bFGF) release their components into the 
surrounding cell environment (Zhu et al., 
2013). This wide variety of growth factors 
and cytokines contribute to multifaceted roles 
of PRP. After addition to in vitro cultures, 
PRP can increase cell proliferation (Kon et 
al., 2010; Filardo et al., 2012), enhance stem 
cell differentiation (Spreafico et al., 2009; 
Smyth et al., 2012, 2013) and raise matrix 
production (Akeda et al., 2006). Also, PRP 
has been used for regenerative injection ther-
apy of osteoarthritis causing symptomatic re-
lief in early osteoarthritis and improving clin-
ical outcome (Filardo et al., 2012; Patel et al., 
2013). PRP has mostly gained its popularity 
as an adjunct to a variety of surgical proce-
dures by reducing postoperative complica-
tions, pain and improving tissue healing 
(Yuan et al., 2012). Clinically, PRP in con-
junction with MSC or AC is applied to partial, 
full, osteochondral and osteoarthritic defects 
(Zhu et al., 2013). Yet, depending on the 
source, preparation protocol and final growth 
factor and cytokine content of PRP, different 
degrees of success have been achieved and 
still up-coming pathologies remain controver-
sial. Of the numerous cytokines and growth 
factors present in PRP lysate, parts of them 
are conducive to maintain the phenotype of 
chondrocytes, others are not (Zhu et al., 
2013). Meanwhile, PRP is proved to have 
both pro- and anti-inflammatory effects (Ani-
tua et al., 2015). 
The classic chondrogenic protocols in-
volving serum-free media supplementation 
with dexamethasone and transforming growth 
factor (TGF-β), though promising in up-regu-
lating cartilage specific matrix molecules, can 
also induce hypertrophic and catabolic mark-
ers (Shen et al., 2014). In order to improve 
chondrogenic differentiation protocols and 
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the resultant MSC derived cartilage neo-tis-
sue, enhanced chondrogenesis of MSCs co-
cultured with chondrocytes has been empha-
sized which is demonstrating higher cartilage 
specific marker expression in the mixed 
groups compared with monocultures as well 
as diminished expression of hypertrophic 
markers (Bian et al., 2011; Babur et al., 2015). 
Development of a reliable chondrogenic dif-
ferentiation protocol without occurrence of 
pathologic or osteoarthritic relevant pheno-
type will prosper clinical stem-cell based car-
tilage repair strategies. 
MSC have established trophy effects to-
wards various cell types (Wu et al., 2012; 
Kabiri et al., 2013). MSC can help chondro-
cytes and get affected by chondrocytes. MSC 
from adipose tissue are shown to effectively 
reduce hypertrophy and dedifferentiation of 
chondrocytes, likely via HGF secretion (Mau-
mus et al., 2013). In direct co-culture with pri-
mary MSC, articular chondrocytes can sup-
press their hypertrophic differentiation and 
prevent matrix calcification (Acharya et al., 
2012). We thus hypothesized that the im-
munomodulatory effects of MSC, trophic ef-
fects of AC and the rich bioactive agents of 
PRP may have synergistic effects on chondro-
genesis with enhancing matrix production and 
dampening hypertrophic differentiation. 
Although both strategies (applying PRP 
and co-culture with AC) have already shown 
to be promising in this regard, there seems to 
be no previous study employing the two in 
combination. Also their effects, alone or in 
combination, on cartilage pathologic marker 
suppression such as inflammation and angio-
genesis, has not yet been addressed. Thus, in 
the current study we aimed to evaluate if the 
unfavorable outcomes, usually concomitant 
with in vitro chondrogenesis, such as hyper-
trophic differentiation, angiogenesis and in-
flammation responses, would get minimized 
using the combination of these two strategies. 
To do that, we made AC-MSC pellet co-cul-
tures and endowed them with PRP and com-
pared their chondrogenic, hypertrophic and 
pathologic marker expression with MSC 
mono-cultures and conventional differentia-
tion methods. 
 
MATERIALS AND METHODS 
Cell isolation and culture 
MSC were isolated from adipose tissue 
obtained from cosmetic liposuction surgeries 
from 3 different donors (aged 18-40, 
Taleghani Hospital, Tehran, Iran) with their 
full consent and willingness according to 
Stem Cells Technologies Research Center 
Ethics guidelines. Adipose resident stem cells 
were isolated as described in details previ-
ously (Shafiee et al., 2016). Cells were ex-
panded and subcultured till passage 6. 
Articular chondrocytes (AC) were iso-
lated from patients with grade 3 or 4 articular 
cartilage damage undergoing knee replace-
ment surgery, after obtaining their consent. 
The cartilage tissue was cut out from the dam-
aged joints and cells were isolated as previ-
ously described (Babur et al., 2015). AC were 
passaged at 80 % confluency and cells at pas-
sages 4-6 were used for the main experiments. 
 
Chondrogenic treatments 
Chondrogenic cultures were formed as 
cell pellets in 15 ml polypropylene conical 
tubes containing 2.5×105 cells per pellet in all 
groups. In co-cultures, MSC were mixed in 
the same pellet with AC at a 10:1 ratio and 
cultured for two weeks. Following pellet for-
mation, in both mono-cultures and co-cul-
tures, media were exchanged with either con-
ventional chondrogenic media containing 
high-glucose DMEM (Invitrogen) supple-
mented with ITS, proline, pyruvate, ascor-
bate-2-phosphate, dexamethasone (all from 
Sigma), TGF-β1 (Peprotech) and pen/strep 
with concentrations described previously 
(Babur et al., 2015), hereafter referred to as 
“Conventional Differentiation, Conv-Diff” 
group or high-glucose DMEM supplemented 
with 10 % PRP and pen/strep referred to as 
“PRP” group. Parallel pellets without any AC 
(MSC mono-cultures) were also treated in the 
same way to figure out the role of AC-MSC 
co-culture. Thus the four groups were named 
as “mono-PRP” and “mono-ConvDiff” for 
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MSC mono-cultures treated with either PRP 
or conventional chondrogenic differentiation 
medium and “Co-PRP” and “Co-ConvDiff” 
for groups containing the 10:1 MSC:AC. All 
pellets were maintained in incubator at 37 ˚C 
in 5 % CO2 for two weeks with media ex-
change twice a week. All the analyses were 
performed at day 14. 
 
PRP preparation 
Whole blood with an anti-coagulant agent 
was collected from volunteer donors. After 
centrifugation (3200 rpm, 10 min) the upper 
plasma phase was collected and centrifuged 
again at 4000 rpm for 15 minutes. The con-
centrated platelets were dispensed in platelet 
poor plasma (PPP), activated with one tenth 
volume of 10 % CaCl2 and incubated over-
night at 4 °C followed by filtration through 
0.2 μm sterile filter on the following day. The 
resultant activated PRP was then stored at -
70 °C and used up to one month (Pakfar et al., 
2017). In order to minimize variations, acti-
vated PRP from three different individuals 
were mixed and used for main experiments. 
 
Real-Time RT-PCR 
Expression pattern of major chondrogenic 
and osteogenic markers was assessed using 
Real-Time RT-PCR after two weeks of chon-
drogenic induction. Total RNA was extracted 
using RNA extraction kit (CinnaGen). cDNA 
was synthesized using a cDNA kit according 
to manufacturer instructions (Takara). The re-
sulted cDNA were evaluated in 40 rounds of 
Real-Time PCR reaction (Corbett) and data 
were analyzed by Rotor Gene Q software. Pri-
mer sequences are demonstrated in Table 1. 
Using ∆∆Ct method, the expression of each 
gene was normalized against β-actin as inter-
nal control and estimated in Co-PRP group 
relative to Co-ConvDiff one and also in 
mono-PRP group relative to mono-ConvDiff 
one in order to underline the effect of PRP 
treatment in either mono or co-culture plat-
form and have them compared with Conv-
Diff media classically used in co-culture ex-
periments. 
 
Table 1: Primer sequences 
Gene name Sequence 
H-beta Actin-F CTT CCT TCC TGG GCA TG 
H-beta Actin-R GTC TTT GCG GAT GTC CAC
SOX9 F TTCCGCGACGTGGACAT 
SOX9 R TCAAACTCGTT-
GACATCGAAGGT 
Aggrecan F TCGAGGACAGCGAGGCC 
Aggrecan R TCGAGGGTGTAGCGTG-
TAGAGA 
Collagen II, 
COL2A1 F
GGCAATAGCAGGTTCAC-
GTACA
Collagen II, 
COL2A1 R
CGATAACAGTCTT-
GCCCCACTT 
Collagen X, 
COL10A1 F
CAAGGCACCATCTCCAGGAA
Collagen X, 
COL10A1 R 
AAAGGGTATTTGTGGCAG-
CATATT 
Versican F TGGAATGATGTTCCCTGCAA 
Versican R AAGGTCTTGGCATTTTC-
TACAACAG 
RunX-2 F GCC TTC AAG GTG GTA GCC 
C
RunX-2 R CGT TAC CCG CCA TGA CAG 
TA
 
Histological analysis (Alcian Blue staining 
and immunocytochemistry) 
After two weeks of induction, the pellets 
were fixed in cold 4 % paraformaldehyde, 
embedded in paraffin, sectioned (5 µm thick) 
and used for immunocytochemistry and Al-
cian Blue staining. After deparaffinization 
and rehydration, antigen retrieval was carried 
out using sodium citrate. The immunostaining 
was carried out using type II Collagen (Col-
II, 1:20 diluted) or type X Collagen (Col-X, 
1:80 diluted) rabbit anti-human primary anti-
bodies (Abcam) at 4 °C overnight and stained 
with PE-conjugated goat anti-rabbit second-
ary antibody (1:100 diluted, 1 h at 37 °C, eBi-
oscience). For GAG staining, the sections 
were stained with Alcian Blue 8GX (Roth) as 
previously described (Shafiee et al., 2011). 
Sections were then photographed using a flu-
orescent microscope (Nikon) assisted with an 
IP-camera (Genucam). 
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Alkaline phosphatase activity 
Alkaline phosphatase (ALP) activity as a 
hypertrophic differentiation marker was as-
sessed by adding 200 µL of RIPA buffer to 
each pellet at day 14 of culture. Cell lysate 
was then centrifuged at 15000 rpm, 4 °C for 
15 min. The supernatant was collected and 
ALP activity was evaluated with an ALP as-
say kit (Parsazmun) according to the manu-
facturers’ instruction. Finally, enzyme activ-
ity was normalized against total protein (BCA 
kit, Life Technologies). 
 
VEGF and TNFα secretion assessment 
In order to evaluate the effect of differen-
tiation treatments and the culture type on se-
cretion of TNFα, a marker of pro-inflamma-
tory responses, by chondrogenic cells at day 
14 the media were collected and quantita-
tively assayed for TNFα secretion. Since PRP 
itself has some endogenous amounts of 
TNFα, in PRP groups the media were ex-
changed with basal media (High Glucose 
DMEM, 1 % ITS) for two days before media 
collection and further TNFα assay by ELISA 
kit (Peprotech). In brief, capture antibody was 
added to the strips after dilution to the work-
ing concentration and incubated overnight as 
per manufacturer’s instruction. After washing 
with 0.05 % Twin 20 in PBS, blocking buffer, 
samples or standards and detection antibody 
were added successively with a washing pro-
cess following each step. TNFα was calcu-
lated by comparison with standard curve. Fi-
nally, the data were normalized against total 
protein content measured by BCA assay kit 
(Life Technologies). 
Likewise, for VEGF assay, culture media 
were collected and used for ELISA using mini 
ELISA development kit (Peprotech) accord-
ing to the manufactures’ instruction. HRP ac-
tivity of the detection antibody was assayed 
using ABTS agent and read at 405 nm. The 
wavelength of 650 nm was used as reference. 
Similar to TNFα assay, the two-day basal me-
dium was collected and used for ELISA. 
 
Statistical analyses 
All tests were carried out in triplicate. 
Data are shown as mean ± SD. For data com-
parison, One-way analysis of variance 
(ANOVA) was used and 0.05 was considered 
as p-value for statistical significance. All sta-
tistical analyses were conducted by SPSS 
software, version 11.0. 
 
RESULTS 
Chondrogenic effects of PRP in mono- and 
co-cultures 
After two weeks of induction with either 
PRP or conventional chondrogenic differenti-
ation media under both mono- and co-culture 
platforms, gene expression was assessed in 
mRNA and protein level. Relative gene ex-
pression was assessed for a panel of chondro-
genic markers using Real Time RT-PCR by 
calculating ∆∆Ct of PRP treated co- and 
mono-culture groups compared against the re-
spective conventional differentiation co- and 
mono-culture groups, respectively, for each 
specific gene. As illustrated in Figure 1, all 
chondrogenic markers examined, including 
Sox-9, Aggrecan, Versican and Col-II were 
significantly increased (from 1.2 to 9.1 folds) 
in PRP groups compared to the conventional 
differentiation control groups (p < 0.05). Ex-
cept for Versican, this increase was more pro-
nounced (with statistically significant differ-
ence, p<0.01) in co-cultures than in mono-
cultures. Which means that PRP has acted 
synergistically with co-culturing method in 
enhancing chondrogenic differentiation of 
MSC. 
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Figure 1: Chondrogenic gene expression after 
two weeks of induction. The data are relative gene 
expression obtained by ∆∆Ct calculations for each 
gene in PRP group relative to Conventional-Dif-
ferentiation control (Conv-Diff). β-actin is used as 
internal control. * indicates significant difference 
between mono- and co-cultures (p<0.05). Except 
for Versican in the co-culture group, the rest of the 
markers showed upregulation in PRP relative to 
Conv-Diff. 
 
 
In terms of protein expression and ECM 
secretion and based on the numerous micro-
graphs analyzed for each treatment, we ob-
served that co-ConvDiff and mono- and co-
PRP groups had deposited more Col-II (Fig-
ure 2A,B) as compared to mono-ConvDiff. 
Though images can just be qualitatively 
judged, obviously the least Col-II secretion 
was observed in mono-ConvDiff group. Alt-
hough no additive effect can be inferred for 
PRP and co-culture, the images show that 
both PRP and co-cultures are privileged in en-
hancing Col-II production which is definitely 
a determinant factor in normal physiology and 
function of the cartilage. In Alcian Blue 
stained sections, all samples were rather sim-
ilar with co-PRP being a bit more stained 
(Figure 2C). These would express that all 
treatments were almost equally effective in 
GAG deposition.
 
 
Figure 2: Chondrogenesis evaluated by ECM production and deposition. A: Expression of Col-II in 
samples stained with PE-conjugated anti-Col-II antibody; Scale bars: 400 µm. B: Same sections stained 
with DAPI, placed beneath the pertinent Col-II micrograph. C: Sections stained with Alcian Blue marking 
GAG production in the ECM of the constructs; Scale bars: 400 µm 
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Hypertrophic differentiation of MSC under 
mono- and co-cultures with PRP or conven-
tional chondrogenic regimens 
The expression of hypertrophic markers 
(Col-X and Runx-2) in terms of mRNA ex-
pression level was decreased in both PRP 
groups (co- and mono-) when compared to the 
corresponding Conv-Diff (co- and mono-) 
groups (Figure 3). Though there was no dif-
ference between mono- and co-cultures in 
RunX-2 expression, the maximal prohibitory 
effects on Col-X expression was observed in 
Co-PRP group, suggesting that PRP and co-
culture had additive effects in suppressing 
Col-X mRNA. Suppression of hypertrophic 
differentiation is of significant importance as 
it could prevent successive tissue ossification 
and cartilage abrasion. We also examined the 
Col-X protein via immunostaining of pellet 
sections. Regarding the point that photo-
graphs were captured with the same light ex-
posure, from the light intensity of the micro-
graphs we can deduce that in all groups less 
type X collagen protein was deposited relative 
to type II collagen, recalling the effectiveness 
of chondrogenesis in all groups. Meanwhile, 
in both mono- and co-cultures receiving 
Conv-Diff media, less Col-X production is 
noticeable than in PRP groups (Figure 4). 
 
Figure 3: Hypertrophic gene expression after two 
weeks of induction. The data are relative gene ex-
pression obtained by ∆∆Ct calculations for each 
gene (RunX-2 and Col-X) in PRP group relative to 
Conventional-Differentiation control (Conv-Diff). 
β-actin is used as internal control. 
 
 
 
ALP as another hypertrophic marker 
showed significantly reduced activity in co-
cultures (both PRP and Conv-Diff) relative to 
mono-cultures (Figure 5A). There was no sig-
nificant difference in each mono- and co-cul-
ture regimens between PRP and conventional 
differentiation groups. In fact it is the pres-
ence of AC that has decreasing effect on ALP 
activity. 
 
 
 
Figure 4: Hypertrophy evaluated by Col-X deposition in ECM. A: Expression of Col-X in samples stained 
with PE-conjugated anti-Col-X antibody; B: Same sections stained with DAPI. Scale bars: 400 µm 
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Figure 5: ALP activity and calcium content as markers of hypertrophic differentiation. A: Normalized 
ALP activity, B: Calcium deposited in the pellets after two weeks of chondrogenic induction. * indicates 
significant difference (p<0.05). Values are mean ±SD. 
 
 
 
Calcium deposition is considered a hall-
mark of osteogenically differentiated cells or 
hypertrophic maturation of chondrogenic 
cells. Among the four different treatments, we 
observed the highest calcium deposition in 
mono-PRP group (Figure 5B). This result was 
rational, since along with chondro-promotive 
factors present in PRP, growth factors such as 
BMP can at least partly induce osteogenesis. 
This effect was somehow abandoned in co-
PRP group, which imparts the suppressive ef-
fects of chondrocytes on osteogenic cues of 
PRP. There was a subtle decreased deposition 
of calcium in co-ConvDiff group relative to 
mono-ConvDiff. Deposited calcium was sig-
nificantly higher in mono-PRP compared to 
mono-ConvDiff and in co-PRP compared to 
co-ConvDiff. 
 
TNFα and VEGF production and secretion 
TNFα is a cytokine involved in systemic 
inflammation. Although it is largely produced 
and secreted by activated macrophages, it can 
also be synthesized by many other cells and 
tissues such as adipose tissue (Kilroy et al., 
2007). In order to assess the inflammatory po-
tential of differentiated cells, TNFα secretion 
was measured quantitatively as shown in Fig-
ure 6A. All four chondrogenic approaches ex-
amined showed reduced TNFα secretion in 
comparison to undifferentiated MSC controls 
(40 %-90 %). Though PRP is mostly privi-
leged for its anti- inflammatory potentials ra-
ther than pro-inflammatory ones, the cells in 
Co-ConvDiff group showed the least TNFα 
secretion. However, when PRP was also in-
cluded co-culturing did not show such sup-
pressing effect. 
VEGF is a signal protein stimulating vas-
culogenesis and angiogenesis. Having consid-
erable amounts of VEGF, PRP has proved an-
giogenic potential. Though suitable for 
wound healing and tissue remodeling, it is not 
desired when it comes to cartilage regenera-
tion. Herein we observed about 50 % increase 
in VEGF secretion in mono-PRP compared to 
MSC controls (Figure 6B). However Co-PRP 
was equal to Co-ConvDiff, recalling that co-
culturing has dampened the angiogenic poten-
tial of PRP. 
 
EXCLI Journal 2017;16:1031-1045 – ISSN 1611-2156 
Received: May 14, 2017, accepted: July 03, 2017, published: July 16, 2017 
 
 
1039 
 
Figure 6: Pathologic markers of chondro-induced pellet cultures. A: TNF-α secretion quantified by 
ELISA; Bars indicate secreted TNF into the media relative to that in undifferentiated MSC controls. B: 
VEGF secretion quantified by ELISA, expressed as values relative to MSC controls. Values are 
mean±SD. 
 
 
 
DISCUSSION 
Chondrocytes are the ideal cell type to re-
pair cartilage lesions, however the required in 
vitro expansion procedure to obtain sufficient 
chondrocytes, usually induces chondrocyte 
dedifferentiation and altered or loss of func-
tionally. So MSC stand out as a promising al-
ternative cell source for cartilage repair. How-
ever, at the late stages of MSC chondrogene-
sis, hypertrophic differentiation and patho-
logic responses can overwhelm MSC applica-
bility. Lately, co-culture of AC and MSC has 
shown to mitigate the above mentioned is-
sues, while PRP has been used in order to fur-
ther enhance the chondrogenesis. We thus as-
sessed the functionality and the combinatory 
effects of PRP with AC:MSC co-culture using 
pellet cultures, aiming to fetch up optimal 
chondrogenesis while minimizing undesired 
hypertrophy and pathologic responses. 
PRP has key molecular sources involved 
in tissue repair and regeneration. However, 
reports on the effects of PRP can be consid-
ered of the most diverse and somehow contra-
dicting ones. Such variety in effects can stem 
from different preparation of PRP and varia-
ble growth factors present in PRP obtained 
from different individuals. To minimize such 
variations we made a pool of activated PRP 
from three different donors and utilized it for 
the main experiments. In line with previous 
studies we observed up-regulation of chon-
drogenic markers in all treatments (Drengk et 
al. 2009). Collectively in both mono- and co-
culture strategies, PRP showed to be a 
stronger inducer of chondrogenesis compared 
with conventional differentiation media con-
taining TGF-β as the only present growth fac-
tor. The highest impact was observed in Ag-
grecan and Col-II mRNA and Col-II protein, 
wherein PRP proved higher chondrogenic 
markers expression. This can be attributed to 
the presence of factors such as bFGF along 
with TGF-β present in PRP, acting in synergy, 
which has led to increased chondrogenesis in 
PRP groups (Böhme et al., 1995; Fischer et 
al., 2010). Such synergistic effect is even 
more pronounced in co-culture groups. That 
is, Sox-9 as an upstream and early regulator 
of cartilage matrix production along with Ag-
grecan and Col-II were significantly upregu-
lated in co-cultures compared to mono-cul-
tures. The enhancive effect of co-culture on 
Col-II protein was only observable for Conv-
Diff treatments with co-ConvDiff secreting 
more Col-II compared to mono-ConvDiff, but 
not in PRP mono- and co-cultures, in which 
both groups were rather similar in producing 
Col-II protein. Nevertheless, in spite of all 
chondro-promotive effects observed in this 
study and proved elsewhere, PRP has osteo-
genic and angiogenic effects as well (Mal-
hotra et al., 2013, Xie et al., 2014). Thus, a 
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more robust survey is required to determine 
whether such phenotypes can lead to patho-
logic outcomes, hindering the usefulness of 
the constructed neo-tissue in cell-therapy ap-
proaches. As such, we stepped forward to as-
sess the hypertrophic, angiogenic and inflam-
matory responses in pellet constructs already 
proved to have good enough chondrogenic 
properties. 
Occurrence of matrix mineralization char-
acterized by alkaline phosphatase activity and 
cell-construct calcification is correlated with 
the formation of an undesirable transient car-
tilage phenotype. However regarding the os-
teoinductive capacity of PRP, it was not un-
likely to witness up-regulation of deposited 
calcium in PRP groups (about 40-50 %) com-
pared to Conv-Diff treatments, with presence 
or absence of AC having not a considerable 
effect on this phenomenon. However, in con-
trast to calcium deposition, ALP activity 
seemed to get influenced more by the pres-
ence of chondrocytes rather than growth fac-
tor supplementation of the medium. 
About 20-25 % decrease in ALP activity 
was observed in co-cultures (both Conv-Diff 
and PRP) in comparison to monoculture 
groups. Collectively speaking, the best treat-
ment with the least calcium deposition and 
ALP activity was co-ConvDiff, while mono-
PRP would rank as the last one. This was also 
inferable from Col-X protein secretion. PRP 
seemed to be more efficacious in suppressing 
hypertrophic markers in mRNA level. While 
AC:MSC coculture proved more efficient in 
reducing Col-X secretion and deposition and 
ALP activity. In line with our study Fischer et 
al. reported down regulation of Col-X/Col-II 
mRNA ratio, the amount of Col-X deposition 
and the ALP activity in co-cultures likely via 
secretory factors present in AC-conditioned 
media. Though, they observed even more pro-
nounced effects in direct co-culture systems 
(Fischer et al., 2010). 
In order to obtain a healthy stable cartilage 
neo-tissue from MSC, the molecular events 
that basically trigger terminal hypertrophic 
differentiation should be suppressed. This is 
particularly challenging since MSC conden-
sation in micro-pellet cultures, as a mimic to 
developmental conditions of cartilage for-
mation, naturally reflects endochondral ossi-
fication. The direct interaction between MSC 
and chondrocytes in pellet co-cultures is 
proved to have inhibitory effects on terminal 
hypertrophic differentiation of MSC during in 
vitro chondrogenesis (Babur et al. 2015). This 
has been attributed to articular chondrocytes 
teaching MSC to obtain and maintain chon-
drocyte phenotype either via direct hetero-
typic cell-cell interactions or soluble factors 
secreted by them (Acharya et al., 2012). We 
thus mixed MSC and chondrocytes in a single 
pellet to provide a direct co-culture system. 
The two cell types were mixed and cultivated 
with 10 % PRP supplement (as a cocktail of 
chondrogenic factors) or under conventional 
chondrogenic medium containing TGF-β, 
since it is needed both to promote MSC chon-
drogenesis and to inhibit chondrocyte dedif-
ferentiation. Dedifferentiated chondrocytes 
not only tend to lose their ability to deposit 
collagen and proteoglycan but also lean to hy-
pertrophic phenotype (Bian et al., 2011). The 
detailed mechanism underlying these effects 
is not well unravelled. However, the soluble 
factors secreted by both cell types and the di-
rect cell-cell contact are known as potent 
means to enhance chondrogenesis and miti-
gate hypertrophic and pathologic develop-
ment of MSCs. Numerous factors have been 
introduced as mediators in the MSC-AC cross 
talk. Of soluble cytokines PTHrP and FGF-2 
are important factors involved in this effect 
(Fischer et al., 2010). Using a rat model and a 
co-culture between MSC and cartilage chips, 
Ahmed et al. suggested VEGF, MMP-13 and 
tissue inhibitor of MMP-1 and 2 as factors in-
volved in the regulation of hypertrophic 
marker (Ahmed et al., 2007). Though such 
proposed factors were not specifically inves-
tigated in our study, we observed that the in-
teraction between the two cell types in the co-
culture system in combination with the vari-
ous factors in PRP resulted in a more robust 
chondrogenesis. 
EXCLI Journal 2017;16:1031-1045 – ISSN 1611-2156 
Received: May 14, 2017, accepted: July 03, 2017, published: July 16, 2017 
 
 
1041 
Clinically, transplantation of MSC to ar-
ticular defects, especially for alleviating ar-
thritis symptoms is highly appreciated. How-
ever, MSCs may secrete high concentration of 
pro-angiogenic cytokines which can over-
whelm their cartilage therapeutic outcomes 
(Duffy et al., 2009). Even pre-differentiated 
chondrogenic MSC constructs transplanted in 
vivo have shown to undergo vascular invasion 
and microossicle formation (Pelttari et al., 
2006). Vascularization occurs as a response to 
VEGF production in the neo-construct. Carti-
lage vascularization is undesired as it can re-
cruit inflammatory cells to the tissue with fol-
lowing interference with healing processes. 
Also, angiogenesis is highly correlated with 
late stages of endochondral ossification and 
osteogenesis (Gerber et al., 1999). As such 
anti-angiogenic factors are highly advised to 
inhibit such pathways. Thus we examined the 
effects of RPP and AC:MSC co-culture and 
their combination on the secretory growth 
factors of differentiated MSC. 
Despite all favorite attributes of PRP, it 
can promote angiogenesis that in the case of 
cartilage tissue is highly undesired. Our result 
showed that the presence of AC could have 
counteracted the angiogenic effects of PRP, 
as in mono-ConvDiff, Co-ConvDiff and Co-
PRP groups there was no elevated levels of 
VEGF as compared to MSC controls. How-
ever mono-PRP treatment showed about 50 
percent increase in VEGF secretion. This sug-
gests that upcoming problems after neo-con-
struct cartilage implantation pertaining to vas-
culogenesis can be diminished by utilizing a 
co-PRP approach. In fact co-PRP has angio-
suppressive effects as deduced from compar-
isons with mono-PRP. This is particularly 
valuable as in cartilage defect therapies using 
PRP, usually an innocuous antagonist or 
VEGF blocking agent such as anti-VEGF an-
tibody is employed (Nagai et al., 2010; Mi-
fune et al., 2013). 
Production and secretion of inflammatory 
factors such as TNFα might lead to cartilage 
matrix degradation which is regulated 
through MAPK and canonical NF-κB path-
ways via inducing the activity of aggre-
canases and MMPs (Wojdasiewicz et al., 
2014). Pro-inflammatory cytokines are partic-
ularly associated with pathogenesis of osteo-
arthritis since they can mediate the catabolic 
pathways in cartilage tissue and trigger re-
cruiting pro-inflammatory cells (Spaková et 
al., 2012). As such suppression of the related 
pathways is highly desired in cartilage tissue 
engineering. PRP has proved anti-inflamma-
tory effects and is widely used to alleviate in-
flammatory symptoms of arthritis (Zhu et al., 
2013, Xie et al., 2014). In all our treated 
groups we observed reduced expression of 
TNFα as compared to MSC controls. Which 
means that pre-differentiation of MSC either 
via traditional chondrogenic protocols or PRP 
supplementation can favor down-regulation 
of inflammatory pathways after cell trans-
plantation to the cartilage defect site. In fact 
the anti-inflammatory effects associated with 
postoperative interventions using PRP can be 
explained by the initial inhibition of macro-
phage proliferation (Zhu et al., 2013). Alt-
hough PRP is mostly known with its anti-in-
flammatory properties, some studies show 
that it can also have pro-inflammatory cyto-
kines such as IL-1β and IL-6 (Zhu et al., 2013; 
Xie et al., 2014). For example the effects of 
PRP on tendon fibroblasts is reported to be in-
duction of inflammatory responses and acti-
vation of oxidative stress pathways (Hudgens 
et al., 2016). 
The pro-inflammatory cytokines in some 
PRP preparations have been attributed to the 
presence or inclusion of leukocytes (of the 
buffy coat) in the final cell/platelet prepara-
tion (Anitua et al., 2015). Herein, we ob-
served the most down-regulation of TNFα in 
co-ConvDiff group, while there was no sig-
nificant difference among the other three 
groups. Which means that AC:MSC co-cul-
ture not only reduces hypertrophic differenti-
ation but also can help dampening inflamma-
tory pathways. Such intensified anti-inflam-
matory effects in co-ConvDiff is not observed 
in co-PRP group, which might be explained 
by the AC cytokines being diluted in the di-
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verse pool of PRP cytokines. In order to coun-
teract or inhibit pro-inflammatory cytokines 
and reduce joint catabolism after cell therapy 
of a defected cartilage, IL-1 receptor antago-
nist protein as well as anti-inflammatory in-
terleukins such as IL-4 and IL-10 can be ap-
plied (Andia and Maffulli, 2013). 
PRP contains hundreds of different bio-
logically active molecules. Chondrocytes and 
even MSC can add to this milieu by secreting 
additional bioactive molecules. The net effect 
on cell fates is thus very unpredictable which 
will even get more complicated regarding the 
numerous PRP preparation protocols and for-
mulations, the way of activation, the endoge-
nous heterogeneity of MSC and AC cultures 
and the age and other complications pertinent 
to cell and blood donors. To mitigate such 
variations and the uncertainty in the biologi-
cal effects we made a pool of PRP from three 
different blood donors and used three MSC 
and two AC donors. Although variations in 
results did exist, the overall trends in the in-
vestigated parameters were rather similar. 
Meanwhile this work had several limitations 
as the neo-cartilage tissues obtained via any 
of the treatments might respond differently in 
vivo. Therefore, a complete examination of 
the chondrogenic, hypertrophic, angiogenic 
and inflammatory markers are needed before 
making any judgment about the prominence 
of any of these treatments to reach the optimal 
protocol with suitable tissue quality. Except 
for the two collagens tested, we did not eval-
uate gene expression in protein level, while it 
is so likely that the changes in mRNA level do 
not correspond to changes in proteins. 
 
CONCLUSION 
By exploiting the benefits of co-culture 
systems of MSC with chondrocytes in pellet 
culture, we sought to evaluate whether 
chondro-promotive effects of PRP and hyper-
trophy-prohibitive effects of AC:MSC co-
culture could be combined with synergistic 
consequences. Regarding problems associ-
ated with MSC transplantation to cartilage le-
sions plus inevitable hypertrophic differentia-
tion of MSC during in vitro chondrogenesis, 
we proposed that by pre-differentiation of 
MSC using PRP and AC:MSC co-culture, the 
chondro-promotive effects of PRP and hyper-
trophy-suppressive effects of AC:MSC co-
culture might sum up in order to obtain a sta-
ble articular chondrocyte phenotype. We 
showed that in both mono- and co-cultures 
PRP significantly induced chondrogenic 
markers expression (Sox-9, Aggrecan, Versi-
can, Col-II) in mRNA level. In protein level 
and ECM secretion, both PRP treatments and 
the co-ConvDiff appeared to deposit high 
amounts of GAG and Col-II. Although PRP 
had down-regulatory effects on hypertrophic 
markers, in mRNA level (Runx-2 and Col-X), 
when it came to protein, co-ConvDiff showed 
the lowest Col-X production. In the same 
way, the co-groups (co-ConvDiff and co-
PRP) had lowered ALP activity compared to 
mono-groups, while PRP had increased cal-
cium deposition compared to ConvDiff 
group. Regarding pathologic proinflamma-
tory and pro-angiogenic markers, we ob-
served that in comparison to conventional 
chondrogenic regimens, PRP is not advised 
since the co-ConvDiff group showed the low-
est TNFα secretion with no stimulatory ef-
fects on VEGF production. Though the mo-
lecular aspects concerning PRP mechanisms 
of action and its crosstalk with MSC and AC 
cells were not addressed and are generally un-
answered, our data showed that all the posi-
tive chondro-promotive effects of PRP and 
hypertrophy-suppressive effects of co-cul-
tures do not necessarily act in synergy, and 
thus we cannot provide firm recommenda-
tions as to which regimen would work opti-
mally for cartilage cell therapy. Nevertheless 
our data showed that PRP acted stronger in 
chondrogenesis while causing some calcium 
deposition and pro-angiogenic effects as well. 
While co-culture was more privileged for 
ALP and Col-X suppression and diminishing 
TNFα production. In spite of striking reduc-
tion in mRNA level of hypertrophic markers, 
the combinatory approach (co-PRP) could not 
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fully attenuate hypertrophic maturation. Nev-
ertheless, in a clinical point of view PRP 
might seem more appealing than conventional 
chondrogenic approach, since it costs less and 
can safely be provided autologously with sig-
nificant chondro-promotive effects. Collec-
tively, we observed synergistic effects for 
PRP and AC:MSC co-culture in enhancing 
chondrogenesis. Also, inclusion of AC could 
reduce some hypertrophic markers and angio-
genic potential in PRP treated groups. We 
thus propose that the combination of PRP and 
co-culture would favor chondrogenesis while 
alleviate but not totally eradicate undesired 
hypertrophic and pathologic responses. 
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